About webmaster-prism

This author has not yet filled in any details.
So far webmaster-prism has created 92 blog entries.

Managing Inventory in an Inventory Optimization World

2021-06-02T16:04:17+00:00May 27th, 2021|Categories: Blog|

Across the board, wholesalers are moving toward inventory optimization – and that makes sense. They’re holding just enough inventory to match demand projections, opting to stay lean and efficient. But while this is the right move for their business, any type of aberration that impacts shipping or demand can cause some serious heartburn for manufacturers, ultimately affecting pharmacies’ abilities to stock product.  It’s up to manufacturers to understand how [...]

Comments Off on Managing Inventory in an Inventory Optimization World

How Do You Know If Your Medical Device Needs State Licensing?

2021-04-28T18:42:12+00:00April 28th, 2021|Categories: Blog|

The medical device industry is growing, and we’re seeing the impact at Two Labs as more and more clients are asking us for support in launching their new medical device products. The medical device industry is projected to grow 6.8% through 2025. One area of planning that these clients are seeking advice on is state licensing. While the state licensing process for a typical new drug launch may be [...]

Comments Off on How Do You Know If Your Medical Device Needs State Licensing?

Mapping the Prescriber Journey: Are you overlooking this key launch planning step?

2021-04-26T14:51:53+00:00March 31st, 2021|Categories: Blog|

During launch planning, many manufacturers place a great deal of emphasis on mapping and understanding the patient journey – and for good reason. The better you understand the patient journey, the better your ability to create a positive patient experience, leading to improved adoption and adherence rates. But while this is important, there’s an equally vital component of the launch strategy that often gets overlooked: mapping the prescriber journey. [...]

Comments Off on Mapping the Prescriber Journey: Are you overlooking this key launch planning step?

5 Ways Compendia Impacts Your Business

2021-03-16T20:00:09+00:00March 16th, 2021|Categories: Blog|

Most manufacturers consider Compendia “price books,” but while pricing is part of Compendia, it’s actually just a small component. Much of the information coming from Compendia is clinical and has an impact on every part of the product decision making process. Unfortunately, most manufacturers don’t fully understand the effect Compendia data has on their launch strategy until something goes wrong. We’ve identified 5 of the biggest ways Compendia [...]

Comments Off on 5 Ways Compendia Impacts Your Business

The Most Important DSCSA Updates for Manufacturers in 2021

2021-03-03T15:31:23+00:00February 24th, 2021|Categories: Blog|

While there may not be new DSCSA regulations going live in 2021, that doesn’t mean manufacturers can take a break from thinking about their DSCSA and serialization strategy this year. The 2023 requirements still loom ahead. In fact, though technical challenges, operational hurdles, and COVID-19 all spurred a delay in the wholesaler saleable returns requirements, the FDA has noted on several occasions that they do not intend to [...]

Comments Off on The Most Important DSCSA Updates for Manufacturers in 2021

Two Labs Expands Leadership Team Along with Appointment of New CEO, Howard Miller

2021-03-31T17:08:21+00:00January 1st, 2021|Categories: News|

Veteran team member promoted to CEO; additional leadership promotions announced to renew focus on client service.   COLUMBUS, Ohio (January 2021) - Two Labs, an industry-leading pharma services company based in Columbus, Ohio, announced several senior leadership promotions today. This comes on the heels of their Nov. 11 announcement of their acquisition by Envision Pharma Group. Along with Howard Miller – who has been with Two Labs for 14 years, [...]

Comments Off on Two Labs Expands Leadership Team Along with Appointment of New CEO, Howard Miller

Two Labs Acquired by Envision Pharma Group

2020-11-12T14:46:50+00:00November 12th, 2020|Categories: News|Tags: |

Envision Pharma Group acquires Two Labs to advance its position as a global strategic partner to pharma and create a unique and unrivaled launch excellence offering Acquisition follows increased investment in Envision from GHO Capital and its partners London, UK, November 12, 2020 Two Labs brings market-leading commercialization, strategic consulting, market access, and market intelligence solutions that span the full product life cycle Move builds on [...]

Comments Off on Two Labs Acquired by Envision Pharma Group

New White Paper: Opportunities and Recent Trends for Biosimilars

2020-10-30T17:31:34+00:00October 30th, 2020|Categories: Blog|

Over the last year, biosimilars have seen increasing success in the US market. The number of biosimilars approved has accelerated, product sales for biosimilars are increasing, net prices are being driven down (for both brands and biosimilars), and payers are beginning to prefer biosimilars over brands on their formularies. In this white paper, we take a closer look at these trends, providing an in-depth analysis of the US [...]

Comments Off on New White Paper: Opportunities and Recent Trends for Biosimilars

TL 3PL Selection Services Highlighted in Pharmaceutical Commerce

2020-10-21T16:43:14+00:00October 5th, 2020|Categories: News|

3PLs aren’t just a logistics solution – they’re an extension of your business, and few things are as important to the success of your launch as selecting the right 3PL partner. In the midst of the pandemic, it’s more important than ever to have the tools you need to effectively vet a 3PL candidate, as introductory meetings and facilities tours are often truncated or entirely virtual. Read more from Jessica [...]

Comments Off on TL 3PL Selection Services Highlighted in Pharmaceutical Commerce

Two Labs Medical Affairs Best Practices Featured in PharmExec

2020-10-21T16:44:32+00:00September 29th, 2020|Categories: News|

Globalizing Medical Affairs can often pull teams away from focusing on their local needs. Our Medical Affairs solution identifies challenges that impede globalization efforts and recommends tactics for optimizing both local and global operations. A one-size-fits-all approach is not sufficient to meet the needs of local and global Medical Affairs – every organization has unique challenges that must be considered in order to successfully globalize. Read more from Two Labs’ [...]

Comments Off on Two Labs Medical Affairs Best Practices Featured in PharmExec
Go to Top